Authors: Otterstad, JE Sleight, P

Citation: Je. Otterstad et P. Sleight, The HOPE study: Comparison with other trials of secondary prevention, EUR HEART J, 22(15), 2001, pp. 1307-1310

Authors: Schumacher, A Lerkerod, AB Seljeflot, I Sommervoll, L Holme, I Otterstad, JE Arnesen, H

Citation: A. Schumacher et al., Chlamydia pneumoniae serology: Importance of methodology in patients with coronary heart disease and healthy individuals, J CLIN MICR, 39(5), 2001, pp. 1859-1864

Authors: Otterstad, JE Ruilope, LM

Citation: Je. Otterstad et Lm. Ruilope, Treatment of hypertension in the very old, INT J CL PR, 2000, pp. 10-19

Authors: Meberg, A Otterstad, JE Froland, G Lindberg, H Sorland, SJ

Citation: A. Meberg et al., Outcome of congenital heart defects - a population-based study, ACT PAEDIAT, 89(11), 2000, pp. 1344-1351

Authors: Otterstad, JE Lubsen, K Parker, A Kirwan, B Plappert, T Sutton, MGS

Citation: Je. Otterstad et al., Left ventricular remodelling in post-myocardial infarction patients with left ventricular ejection fraction 40-50% vs 25-39%. influence of nisoldipine treatment? An echocardiographic substudy from the DEFIANT II study, SC CARDIOVA, 33(4), 1999, pp. 234-241

Authors: Meberg, A Otterstad, JE Froland, G Hals, J Sorland, SJ

Citation: A. Meberg et al., Early clinical screening of neonates for congenital heart defects: the cases we miss, CARD YOUNG, 9(2), 1999, pp. 169-174